This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
@RNAiAnalyst
rnaianalyst.bsky.social
did:plc:tejtguno6cesjnl7gak2ejfr
#Alnylam trades at a 50x market cap of #Intellia directly exposed to CRISPR for many of its high-value liver indications.
How on earth do they not have strategic option to #CRISPR, even through a 50:50-type partnership with a leading CRISPR Co if not in-house?
#RNAediting similar situation.
2025-05-18T18:23:23.853Z